Building Flexible, Scalable and Sustainable Cell Therapy Manufacturing Network to Serve Patients
November 24, 2023
Rob Zamboldi is the Site Head and General Manager of Novartis’ flagship cell processing operation in Morris Plains, NJ providing worldwide supply of novel CAR-T therapies. Rob was instrumental in the ramp up of the first to market CAR-T, Kymriah ® of which more than 7,000 treatments have been supplied from his facility.
Continue readingLeave a comment
